AU1051695A - Beneficial wound healing applications of calreticulin and other hyaluronan-associated proteins - Google Patents

Beneficial wound healing applications of calreticulin and other hyaluronan-associated proteins

Info

Publication number
AU1051695A
AU1051695A AU10516/95A AU1051695A AU1051695A AU 1051695 A AU1051695 A AU 1051695A AU 10516/95 A AU10516/95 A AU 10516/95A AU 1051695 A AU1051695 A AU 1051695A AU 1051695 A AU1051695 A AU 1051695A
Authority
AU
Australia
Prior art keywords
calreticulin
hyaluronan
wound healing
associated proteins
healing applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10516/95A
Inventor
Hari G Garg
Leslie I. Gold
John W. Siebert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
New York University NYU
Original Assignee
General Hospital Corp
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp, New York University NYU filed Critical General Hospital Corp
Publication of AU1051695A publication Critical patent/AU1051695A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU10516/95A 1993-11-19 1994-11-08 Beneficial wound healing applications of calreticulin and other hyaluronan-associated proteins Abandoned AU1051695A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/155,933 US5591716A (en) 1993-11-19 1993-11-19 Beneficial wound healing applications of calreticulin and other hyaluronan-associated proteins
US155933 1993-11-19
PCT/US1994/012853 WO1995013828A1 (en) 1993-11-19 1994-11-08 Beneficial wound healing applications of calreticulin and other hyaluronan-associated proteins

Publications (1)

Publication Number Publication Date
AU1051695A true AU1051695A (en) 1995-06-06

Family

ID=22557366

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10516/95A Abandoned AU1051695A (en) 1993-11-19 1994-11-08 Beneficial wound healing applications of calreticulin and other hyaluronan-associated proteins

Country Status (3)

Country Link
US (1) US5591716A (en)
AU (1) AU1051695A (en)
WO (1) WO1995013828A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171864B1 (en) * 1996-07-05 2001-01-09 Pioneer Hi-Bred International, Inc. Calreticulin genes and promoter regions and uses thereof
US6559287B1 (en) 1998-01-24 2003-05-06 Bristol-Myers Squibb Co. Artificial proteoglycans
PT1100529E (en) * 1998-07-30 2005-10-31 Us Gov Health & Human Serv TIMOSINA BETA 4 PROMOTES WOUND PREPARATION
US20080096817A1 (en) * 1998-07-30 2008-04-24 Regenerx Biopharmaceuticals, Inc. METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN BETA 4 (Tbeta4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES
US20040067227A1 (en) * 2001-11-02 2004-04-08 Goldstein Allan L. Inhibition or reversal of skin aging by actin-sequestering peptides
US6596690B2 (en) 1998-10-06 2003-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vasostatin as marrow protectant
US6867180B1 (en) * 1998-10-06 2005-03-15 The United States Of America As Represented By The Department Of Health And Human Services Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth
WO2000020577A1 (en) * 1998-10-06 2000-04-13 The Government Of The United States Of America, Represented By The Secretary, Dept. Of Health And Huuman Services, The National Institutes Of Health Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth
US7261881B1 (en) 1999-05-20 2007-08-28 Yale University Modulation of angiogenesis and wound healing
US8128922B2 (en) * 1999-10-20 2012-03-06 Johns Hopkins University Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
ES2454640T3 (en) * 2000-08-03 2014-04-11 Johns Hopkins University Molecular vaccine that carries a chaperone polypeptide from the endoplasmic reticulum to an antigen
US6599526B2 (en) * 2000-08-18 2003-07-29 The University Of North Texas Health Science Center At Fort Worth Pericardial anti-adhesion patch
US6426220B1 (en) 2000-10-30 2002-07-30 Isis Pharmaceuticals, Inc. Antisense modulation of calreticulin expression
EP1644048B1 (en) * 2003-05-05 2015-04-29 Johns Hopkins University Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
WO2006029046A2 (en) * 2004-09-03 2006-03-16 Yale University Use of leptin in wound healing
CA2594040A1 (en) * 2005-01-06 2006-07-13 The Johns Hopkins University Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
EP1846026A4 (en) * 2005-01-26 2008-07-02 Univ Johns Hopkins Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
US20100330105A1 (en) * 2006-08-22 2010-12-30 John Hopkins University Anticancer Combination Therapies
KR101509139B1 (en) * 2006-11-23 2015-04-08 주식회사 엘지생명과학 Method for purifying hyaluronic acid
US9085638B2 (en) 2007-03-07 2015-07-21 The Johns Hopkins University DNA vaccine enhancement with MHC class II activators
US20080260765A1 (en) * 2007-03-15 2008-10-23 Johns Hopkins University HPV DNA Vaccines and Methods of Use Thereof
US20090285861A1 (en) * 2008-04-17 2009-11-19 Tzyy-Choou Wu Tumor cell-based cancer immunotherapeutic compositions and methods
US8129341B2 (en) * 2008-08-25 2012-03-06 New York University Methods for treating diabetic wounds
WO2011097342A1 (en) * 2010-02-04 2011-08-11 University Of Utah Research Foundation Hydrophobically-modified hyaluronan and methods of making and using thereof
CA2805412C (en) 2010-06-17 2021-04-27 New York University Therapeutic and cosmetic uses and applications of calreticulin
WO2018067854A1 (en) * 2016-10-06 2018-04-12 Ramp Research, Llc Methods, compositions, and kits involving alteration of the chaperone protein axis in a subject
WO2024091513A1 (en) * 2022-10-24 2024-05-02 New York University Biomimetic extracellular matrix nanofibers electrospun with calreticulin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US5124392A (en) * 1988-10-03 1992-06-23 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
WO1992002247A1 (en) * 1990-08-01 1992-02-20 Chiron Ophthalmics, Inc. Method for treating corneal endothelial wounds

Also Published As

Publication number Publication date
WO1995013828A1 (en) 1995-05-26
US5591716A (en) 1997-01-07

Similar Documents

Publication Publication Date Title
AU1051695A (en) Beneficial wound healing applications of calreticulin and other hyaluronan-associated proteins
US5401504B1 (en) Use of tumeric in wound healing
AU6391394A (en) Medical devices and methods of manufacture
AU1054592A (en) Method of immobilizing and crosslinking proteins and other molecules and uses thereof
AU7516694A (en) Biotinylation of proteins
AU663826B2 (en) Portable and dynamic distributed applications architecture
AU7830194A (en) Instruction mapping system and method of manufacture
AU6268594A (en) Novel silico-titanates and their methods of making and using
AU6833994A (en) Incorporation of taxol into liposomes and gels
AU6174994A (en) Detection of type ii collagen and its peptides
AU8011694A (en) Casket and method of making same
AU6847894A (en) Method for the improvement of wound healing and compositions therefor
AU7400091A (en) Inhibitors of the advanced glycosylation of proteins and methods of use therefor
AU4981390A (en) Handbrush and method of manufacture thereof
AU6198894A (en) Monitoring and control of chiller units
AU4013495A (en) Chemokine-like proteins and methods of use
AU4354589A (en) Surgical instruments and assemblies
AU1054795A (en) Method of forming self-texturing filaments and resulting self-texturing filaments
AU6905894A (en) Trichohyalin and transglutaminase-3 and methods of using same
AU1435695A (en) Recombinant human thymopoietin proteins and uses therefor
AU7395194A (en) Neomorphic ibuprofen and methods of using same
AU2706688A (en) Ionic semiconductor materials and applications therefor
AU6723294A (en) Use of simmondsine
AU6651794A (en) Automatisation of electro-oculographic examination
AU4219097A (en) Manufacture of planar waveguide and planar waveguide